chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered 3 vaccines beyond the beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 3 vaccines beyond the beyond use date) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 022J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 14-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 3 vaccines beyond the beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 3 vaccines beyond the beyond use date) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that the pharmacy administered 3 vaccines beyond the beyond use date a couple of months ago. The health officials were requiring them to get this settled out before they could get some more vaccines. Date the vial was initially stored in the refrigerator was possibly 10-Jan-2202, 11-Jan-2022, or 12-Jan-2022. Vail did not undergo any temperature excursions. No treatment medications were provided.   This case was linked to MOD-2022-566953, MOD-2022-566958 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Follow-up received contain no new information
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Documented hypersensitivity to administered product, Tachycardia, Wrong product administered
Clinical narrative: Systemic: It was ordered to not give the vaccine to patient due to previous allergy. information of type of allergy, when did it started, for how long had the reaction was not provided. note on system was posted 4/25/22. vaccine was given on 4/29/22.-Mild, Systemic: Tachycardia-Mild, Error: Wrong Vaccine/Product Administered-, Additional Details: the patient got allergic reaction from first shot. It was ordered to not give the vaccine to patient due to previous allergy. information of type of allergy, when did it started, for how long had the reaction was not provided. note on system was posted 4/25/22. vaccine was given on 4/29/22. caregiver called in reporting an adverse event and mentioning decision. no information about allergy type, when, for how long was provided.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Flushing, Headache, Hyperhidrosis, Hypertension, Nausea
Clinical narrative: Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Hypertension-Medium, Systemic: Nausea-Medium
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Lymphadenopathy, Rash
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Lymph Node Swelling-Medium, Additional Details: Patient received vaccine on 5/7. Antibiotic prescription was sent on 5/10 and patient reported swelling/rash in injection arm that had spread to lymph nodes. Called patient on 5/12/22 and states arm is much better and no longer having issues.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Dysphagia, Dyspnoea, Throat tightness, Vomiting
Clinical narrative: Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Vomiting-Medium
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Pt has not reported any adverse event, but they inadvertently received a 2nd booster (4th dose), after stating that they were not immunocompromised.  1st booster was received on 10/26/21 and 2nd booster on 5/16/22/
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Influenza A virus test positive, Influenza B virus test positive, Oropharyngeal pain
Clinical narrative: Breakthrough COVID infection. Sore throat and some SOB
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID infection. Sore throat and some SOB
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna 3/24/21, 4/21/21, 11/20/21. Positive on 5/12/22
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD DATE 4/7/2022  Booster given 04/14/2022 Pfizer could not verify stability beyond 4//9/2022 and recommended revaccinating so another booster given  on 05/11/2022
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration past expiration date. Moderna has confirmed vaccine was still viable at the time of administration.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 60.0
Sex: F
Vaccine: UNK
Symptoms: Hyperaesthesia, Post herpetic neuralgia
Clinical narrative: Post herpetic neuralgia - first along pantylines in front of hip bones a few days after shot and now front of right thigh very sensitive to the touch.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol, Cataract, Cataract operation, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Prior to receiving my vaccine, I was starting to develop cataracts in both of my eyes and I had minor symptoms of COPD. About one week after receiving my vaccine, I started experiencing shortness of breath walking from my TV room to the bathroom and that is about 20 feet. My cataracts become full blown and I had to have surgery within 2 months after receiving my vaccine. I had to have both eyes operated on. My COPD is almost full blown. For right now, I am using an inhaler before any other options are available.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Glycosylated haemoglobin, Laboratory test
Clinical narrative: Prior to receiving my vaccine, I was starting to develop cataracts in both of my eyes and I had minor symptoms of COPD. About one week after receiving my vaccine, I started experiencing shortness of breath walking from my TV room to the bathroom and that is about 20 feet. My cataracts become full blown and I had to have surgery within 2 months after receiving my vaccine. I had to have both eyes operated on. My COPD is almost full blown. For right now, I am using an inhaler before any other options are available.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer Covid vaccine that expired 23 days prior.  Patient and physician have been notified
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Bud date 04/07/2022 consulted Pfizer who could not provide stability data beyond 04/09/2022 and recommended revaccination. Another booster provided on 05/11/2022
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, COVID-19, Computerised tomogram abdomen abnormal, Cough, Diarrhoea
Clinical narrative: Patient arrives via EMS with complaint of nausea, vomiting, and diarrhea that started today.  Patient just had a positive COVID test today.  Patient states she felt fine yesterday.  Patient denies shortness of breath, does admit to an occasional cough.  Patient denies fever, chills, chest pain, or rash.  Patient lives at an ECF.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hypoxia, Mucosal disorder, Nausea, SARS-CoV-2 test positive
Clinical narrative: Patient arrives via EMS with complaint of nausea, vomiting, and diarrhea that started today.  Patient just had a positive COVID test today.  Patient states she felt fine yesterday.  Patient denies shortness of breath, does admit to an occasional cough.  Patient denies fever, chills, chest pain, or rash.  Patient lives at an ECF.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Vomiting, White blood cell count increased
Clinical narrative: Patient arrives via EMS with complaint of nausea, vomiting, and diarrhea that started today.  Patient just had a positive COVID test today.  Patient states she felt fine yesterday.  Patient denies shortness of breath, does admit to an occasional cough.  Patient denies fever, chills, chest pain, or rash.  Patient lives at an ECF.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, not boosted. COVID breakthrough infection
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration past expiration date.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with J&J. One booster.   COVID infection breakthrough
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD Date 04/07/2022 administered 04/16/2022.Pfizer consulted and could not provide stability data beyond 04/09/2022 and recommended revaccination which was provided on 05/11/2022
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Headache, Oral pain, Pyrexia, Respiratory tract congestion
Clinical narrative: I experienced runny nose, congestion, headaches, fever of 102, ear aches and mouth aches.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: I experienced runny nose, congestion, headaches, fever of 102, ear aches and mouth aches.
Age: 100.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted. COVID-19 infection breakthrough.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: Within a week or so I developed arthritis on the right side of my body; knee, hip, elbow, and possibly jaw.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration past expiration date. Moderna has confirmed vaccine was still viable at the time of administration.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD 04/07/2022 administered 04/12/2022. Consulted Pfizer who could  not provide stability data beyond 04/09/2022 and recommended revaccination which was provided on 05/13/2022
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Malaise
Clinical narrative: Swelling, redness, pain, itching at injection site; malaise, muscle aches, low fever
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Pyrexia
Clinical narrative: Swelling, redness, pain, itching at injection site; malaise, muscle aches, low fever
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration past expiration date. Moderna has confirmed vaccine was still viable at the time of administration.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: On the 9th, I woke up with a post-nasal drip and a sore throat. The next morning, I had a slight fever and felt congested as my sore throat got worse. I took some Tylenol. I woke up from my nap and did an at-home test of COVID-19. The test came back positive, so I called my doctor's office and they prescribed me Afrin and told me to continue to take ibuprofen for the pain and to stay hydrated. I used the nasal spray 3 times a day and ate cough drops as well to help with my sore throat. After 2 or 3 days or so, I began feeling better.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Upper-airway cough syndrome
Clinical narrative: On the 9th, I woke up with a post-nasal drip and a sore throat. The next morning, I had a slight fever and felt congested as my sore throat got worse. I took some Tylenol. I woke up from my nap and did an at-home test of COVID-19. The test came back positive, so I called my doctor's office and they prescribed me Afrin and told me to continue to take ibuprofen for the pain and to stay hydrated. I used the nasal spray 3 times a day and ate cough drops as well to help with my sore throat. After 2 or 3 days or so, I began feeling better.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given to patient and there was no adverse reaction.  Vaccine expiry date was 05/31/2022 and beyond date use was 04/19/2022.  Contacted the patient and they had no side effects.   There was no temperature excursion during the storage of vaccine since the time vaccine was received.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Breakthrough case of COVID-19.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: bud 04/07/2022 administered 04/14/2022. Consulted Pfizer who could not provide stability beyond 04/09/2022 and recommended revaccination provided another  booster05/13/2022
Age: 1.08
Sex: F
Vaccine: HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Reports leg redness and hardness
Age: 1.67
Sex: M
Vaccine: DTAP, HEPA, HIBV
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Nurse administering vaccines administered two Dtaps instead of one dtap and one prevnar.  Patient's parent notified of incident and voiced no concerns. We offered for them to return same day or reschedule for a different day to receive the vaccine that was missed but they declined and would call back.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Computerised tomogram head normal, Dizziness, Epistaxis, Exposure during pregnancy
Clinical narrative: Early Morning April 28.2022. I had woken up in the middle of the evening to use the restroom. Probably between 430 and 530am. At some point I believe I fell and hit my head on the counter. I had goose eggs on the right side of my head and there were things knocked off of the counter with pain on the right side of my body. My son came to wake me up because I hadn't woken him for school. He struggled to wake me and was finally able to call my mother who looked me over. When she arrived, I wasn't able to form full sentences and was struggling to get even one word out. She ended up taking me to the ER after calling my OB. Once we got to the ER they did a urine sample and blood work and a mental evaluation to rule out a stroke. They were concerned specifically about my inability to speak properly which lasted from about 9am-2pm that day. My speech ability gradually returned and improved from one word at a time to full sentences. They also did a CT scan for blood bleeds and monitored my blood pressure which was high. But they attributed that to nerves. They then sent me to labor and delivery for monitoring of the baby. The baby seemed fine and was moving as expected. The doctor came in and mentioned seizure activity and suggested that I see a neurologist. I had an appointment after that with a doctor and am waiting on an appointment with the neurologist. I haven't had any other episodes but have had moments of dizziness that pass after resting for a bit. I am also monitoring my blood pressure regularly. 20 weeks pregnant at time of adverse event. Estimated due date September 13, 2022.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Head injury, Hypertension, Pain, Sleep disorder
Clinical narrative: Early Morning April 28.2022. I had woken up in the middle of the evening to use the restroom. Probably between 430 and 530am. At some point I believe I fell and hit my head on the counter. I had goose eggs on the right side of my head and there were things knocked off of the counter with pain on the right side of my body. My son came to wake me up because I hadn't woken him for school. He struggled to wake me and was finally able to call my mother who looked me over. When she arrived, I wasn't able to form full sentences and was struggling to get even one word out. She ended up taking me to the ER after calling my OB. Once we got to the ER they did a urine sample and blood work and a mental evaluation to rule out a stroke. They were concerned specifically about my inability to speak properly which lasted from about 9am-2pm that day. My speech ability gradually returned and improved from one word at a time to full sentences. They also did a CT scan for blood bleeds and monitored my blood pressure which was high. But they attributed that to nerves. They then sent me to labor and delivery for monitoring of the baby. The baby seemed fine and was moving as expected. The doctor came in and mentioned seizure activity and suggested that I see a neurologist. I had an appointment after that with a doctor and am waiting on an appointment with the neurologist. I haven't had any other episodes but have had moments of dizziness that pass after resting for a bit. I am also monitoring my blood pressure regularly. 20 weeks pregnant at time of adverse event. Estimated due date September 13, 2022.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Urine analysis normal
Clinical narrative: Early Morning April 28.2022. I had woken up in the middle of the evening to use the restroom. Probably between 430 and 530am. At some point I believe I fell and hit my head on the counter. I had goose eggs on the right side of my head and there were things knocked off of the counter with pain on the right side of my body. My son came to wake me up because I hadn't woken him for school. He struggled to wake me and was finally able to call my mother who looked me over. When she arrived, I wasn't able to form full sentences and was struggling to get even one word out. She ended up taking me to the ER after calling my OB. Once we got to the ER they did a urine sample and blood work and a mental evaluation to rule out a stroke. They were concerned specifically about my inability to speak properly which lasted from about 9am-2pm that day. My speech ability gradually returned and improved from one word at a time to full sentences. They also did a CT scan for blood bleeds and monitored my blood pressure which was high. But they attributed that to nerves. They then sent me to labor and delivery for monitoring of the baby. The baby seemed fine and was moving as expected. The doctor came in and mentioned seizure activity and suggested that I see a neurologist. I had an appointment after that with a doctor and am waiting on an appointment with the neurologist. I haven't had any other episodes but have had moments of dizziness that pass after resting for a bit. I am also monitoring my blood pressure regularly. 20 weeks pregnant at time of adverse event. Estimated due date September 13, 2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was administered patient on 05/10/2022.  As per manufacturer expiry date of vaccine was 07/08/2022 but beyond use date was 04/21/22.  Contacted the patient and patient has no adverse reaction due to vaccine.  There was no temperature excursion during storage of vaccine since vaccine was received at pharmacy.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Malaise, Nasal congestion
Clinical narrative: Covid symptoms started 04/25/22; tested positive on 04/27/22. Symptoms were stuffy nose, congestion, coughing, sore throat, and slight headache. I went to doctor on 04/26/22 and got antibiotic's and coughing pills. Symptom's lasted for a week and a half. I do still have sinus drainage and coughing. First vaccine was J&J 03/2021.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Paranasal sinus hypersecretion, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Covid symptoms started 04/25/22; tested positive on 04/27/22. Symptoms were stuffy nose, congestion, coughing, sore throat, and slight headache. I went to doctor on 04/26/22 and got antibiotic's and coughing pills. Symptom's lasted for a week and a half. I do still have sinus drainage and coughing. First vaccine was J&J 03/2021.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Diarrhoea, Electrocardiogram abnormal, Erythema, Feeling abnormal
Clinical narrative: About five hours after I got my second booster I feeling a little off with flu like symptoms. By 2AM I was flushed and turning red, I was achy and feeling the spins and had heart palpitations. I woke up Friday and could not even sit up and ended up staying in a Benadryl coma. I was vomiting and having diarrhea. I even took a Covid and that came back negative. I started feeling this impending doom. I became flush and my heart rate sky rocketed into the 140's I was on hold trying to talk to my doctor and then my throat starting closing and I had to use my EpiPen and called 911.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Heart rate increased, Influenza like illness, Metabolic function test, Mobility decreased
Clinical narrative: About five hours after I got my second booster I feeling a little off with flu like symptoms. By 2AM I was flushed and turning red, I was achy and feeling the spins and had heart palpitations. I woke up Friday and could not even sit up and ended up staying in a Benadryl coma. I was vomiting and having diarrhea. I even took a Covid and that came back negative. I started feeling this impending doom. I became flush and my heart rate sky rocketed into the 140's I was on hold trying to talk to my doctor and then my throat starting closing and I had to use my EpiPen and called 911.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation, Pain, Palpitations, Platelet count decreased, SARS-CoV-2 test negative
Clinical narrative: About five hours after I got my second booster I feeling a little off with flu like symptoms. By 2AM I was flushed and turning red, I was achy and feeling the spins and had heart palpitations. I woke up Friday and could not even sit up and ended up staying in a Benadryl coma. I was vomiting and having diarrhea. I even took a Covid and that came back negative. I started feeling this impending doom. I became flush and my heart rate sky rocketed into the 140's I was on hold trying to talk to my doctor and then my throat starting closing and I had to use my EpiPen and called 911.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, Vertigo, Vomiting
Clinical narrative: About five hours after I got my second booster I feeling a little off with flu like symptoms. By 2AM I was flushed and turning red, I was achy and feeling the spins and had heart palpitations. I woke up Friday and could not even sit up and ended up staying in a Benadryl coma. I was vomiting and having diarrhea. I even took a Covid and that came back negative. I started feeling this impending doom. I became flush and my heart rate sky rocketed into the 140's I was on hold trying to talk to my doctor and then my throat starting closing and I had to use my EpiPen and called 911.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Pfizer 3/31/21 ER8727 dose 1 Pfizer 4/22/21  EW0158
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received Pfizer vaccine on 04/28/2022.  Vaccine expiry date as per manufacturer was 05/31/22  but beyond use date was 04/21/22.  Talked to patient they had no adverse reaction.  There was no temperature excursion during storage of vaccine after receiving in pharmacy.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration past expiration date. Moderna has confirmed vaccine was still viable at the time of administration.
Age: 24.0
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pt tested positive for Covid.  Pt received full Covid Vaccination
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood chloride decreased, Blood glucose normal, Blood osmolarity decreased, Blood sodium decreased, C-reactive protein increased
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/30/21 (ER8727) Pfizer Dose 2 4/21/21 (ER8731) COVID Positive 11/30/21 COVID Positive 12/2/21  12/2/21: Patient is a 59-year-old male with past medical history significant for COPD, OSA on CPAP, obesity, hyperlipidemia, history of PE currently anticoagulated on Eliquis, IFG, hypertension, and anxiety.  The patient presents to the ED today via EMS from home with complaints of worsening shortness of breath.  The patient tested positive for COVID-19 3 days ago.  The patient states his symptoms started on 11/26/2021.  He states his shortness of breath has worsened over the last 2 days and admits to frequent cough attacks causing him to become lightheaded and significantly dyspneic.  The patient's accompanying symptoms include fever, chills, cough, dizziness, lightheadedness, nausea and fatigue.  The patient denies any chest pain, diarrhea, loss of taste or smell, vomiting or abdominal pain.  The patient has been using albuterol nebulizer treatments at home without relief of symptoms. The patient denies ever being on oxygen supplementation in the past.  The patient is vaccinated against COVID-19.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use.  The patient is a former smoker, quit 5 years ago.   The patient presents via EMS - his oxygen saturation was 87% on room air EN route, patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%.  Upon arrival to ED patient's temperature is 100.9°, heart rate 91, respirations 18, pulse ox 93% on 4 L oxygen via nasal cannula, blood pressure 125/94.  Chest x-ray reveals patchy bilateral pulmonary infiltrate/airspace disease consistent with COVID-19 pneumonia.  Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 112, calc Osmo 266, CRP 12.70, D-dimer 0.78.  Patient received 1 g p.o. Tylenol, DuoNeb x1, 500 mg IV azithromycin, 1 g IV Rocephin, 6 mg IV Decadron in ED.  12/6/21: 59-year-old man who presented worsening fever, myalgias, shortness of breath following diagnosis of COVID-19 infection 3 days prior.  He was found to be hypoxic on evaluation in the emergency department requiring initiation of supplemental oxygen, Chest x-ray demonstrated bilateral patchy infiltrates.  He was admitted to the hospitalist service where he was started on treatment with IV Decadron, remdesivir and empiric antibiotic therapy.  Abruptly worsening oxygen requirements were noted requiring initiation of high-flow oxygen up to 12 liters/minute.  Pulmonary was consulted, he was given a dose of Actemra with marked in improvement in CRP levels and subsequent improvement in oxygen requirements.  Oxygen walk was done for home determination done today, he did not meet criteria for home oxygen at this time.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills, Cough
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/30/21 (ER8727) Pfizer Dose 2 4/21/21 (ER8731) COVID Positive 11/30/21 COVID Positive 12/2/21  12/2/21: Patient is a 59-year-old male with past medical history significant for COPD, OSA on CPAP, obesity, hyperlipidemia, history of PE currently anticoagulated on Eliquis, IFG, hypertension, and anxiety.  The patient presents to the ED today via EMS from home with complaints of worsening shortness of breath.  The patient tested positive for COVID-19 3 days ago.  The patient states his symptoms started on 11/26/2021.  He states his shortness of breath has worsened over the last 2 days and admits to frequent cough attacks causing him to become lightheaded and significantly dyspneic.  The patient's accompanying symptoms include fever, chills, cough, dizziness, lightheadedness, nausea and fatigue.  The patient denies any chest pain, diarrhea, loss of taste or smell, vomiting or abdominal pain.  The patient has been using albuterol nebulizer treatments at home without relief of symptoms. The patient denies ever being on oxygen supplementation in the past.  The patient is vaccinated against COVID-19.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use.  The patient is a former smoker, quit 5 years ago.   The patient presents via EMS - his oxygen saturation was 87% on room air EN route, patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%.  Upon arrival to ED patient's temperature is 100.9°, heart rate 91, respirations 18, pulse ox 93% on 4 L oxygen via nasal cannula, blood pressure 125/94.  Chest x-ray reveals patchy bilateral pulmonary infiltrate/airspace disease consistent with COVID-19 pneumonia.  Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 112, calc Osmo 266, CRP 12.70, D-dimer 0.78.  Patient received 1 g p.o. Tylenol, DuoNeb x1, 500 mg IV azithromycin, 1 g IV Rocephin, 6 mg IV Decadron in ED.  12/6/21: 59-year-old man who presented worsening fever, myalgias, shortness of breath following diagnosis of COVID-19 infection 3 days prior.  He was found to be hypoxic on evaluation in the emergency department requiring initiation of supplemental oxygen, Chest x-ray demonstrated bilateral patchy infiltrates.  He was admitted to the hospitalist service where he was started on treatment with IV Decadron, remdesivir and empiric antibiotic therapy.  Abruptly worsening oxygen requirements were noted requiring initiation of high-flow oxygen up to 12 liters/minute.  Pulmonary was consulted, he was given a dose of Actemra with marked in improvement in CRP levels and subsequent improvement in oxygen requirements.  Oxygen walk was done for home determination done today, he did not meet criteria for home oxygen at this time.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Fibrin D dimer, Hypoxia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/30/21 (ER8727) Pfizer Dose 2 4/21/21 (ER8731) COVID Positive 11/30/21 COVID Positive 12/2/21  12/2/21: Patient is a 59-year-old male with past medical history significant for COPD, OSA on CPAP, obesity, hyperlipidemia, history of PE currently anticoagulated on Eliquis, IFG, hypertension, and anxiety.  The patient presents to the ED today via EMS from home with complaints of worsening shortness of breath.  The patient tested positive for COVID-19 3 days ago.  The patient states his symptoms started on 11/26/2021.  He states his shortness of breath has worsened over the last 2 days and admits to frequent cough attacks causing him to become lightheaded and significantly dyspneic.  The patient's accompanying symptoms include fever, chills, cough, dizziness, lightheadedness, nausea and fatigue.  The patient denies any chest pain, diarrhea, loss of taste or smell, vomiting or abdominal pain.  The patient has been using albuterol nebulizer treatments at home without relief of symptoms. The patient denies ever being on oxygen supplementation in the past.  The patient is vaccinated against COVID-19.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use.  The patient is a former smoker, quit 5 years ago.   The patient presents via EMS - his oxygen saturation was 87% on room air EN route, patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%.  Upon arrival to ED patient's temperature is 100.9°, heart rate 91, respirations 18, pulse ox 93% on 4 L oxygen via nasal cannula, blood pressure 125/94.  Chest x-ray reveals patchy bilateral pulmonary infiltrate/airspace disease consistent with COVID-19 pneumonia.  Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 112, calc Osmo 266, CRP 12.70, D-dimer 0.78.  Patient received 1 g p.o. Tylenol, DuoNeb x1, 500 mg IV azithromycin, 1 g IV Rocephin, 6 mg IV Decadron in ED.  12/6/21: 59-year-old man who presented worsening fever, myalgias, shortness of breath following diagnosis of COVID-19 infection 3 days prior.  He was found to be hypoxic on evaluation in the emergency department requiring initiation of supplemental oxygen, Chest x-ray demonstrated bilateral patchy infiltrates.  He was admitted to the hospitalist service where he was started on treatment with IV Decadron, remdesivir and empiric antibiotic therapy.  Abruptly worsening oxygen requirements were noted requiring initiation of high-flow oxygen up to 12 liters/minute.  Pulmonary was consulted, he was given a dose of Actemra with marked in improvement in CRP levels and subsequent improvement in oxygen requirements.  Oxygen walk was done for home determination done today, he did not meet criteria for home oxygen at this time.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Lung disorder, Lung infiltration, Myalgia, Nausea
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/30/21 (ER8727) Pfizer Dose 2 4/21/21 (ER8731) COVID Positive 11/30/21 COVID Positive 12/2/21  12/2/21: Patient is a 59-year-old male with past medical history significant for COPD, OSA on CPAP, obesity, hyperlipidemia, history of PE currently anticoagulated on Eliquis, IFG, hypertension, and anxiety.  The patient presents to the ED today via EMS from home with complaints of worsening shortness of breath.  The patient tested positive for COVID-19 3 days ago.  The patient states his symptoms started on 11/26/2021.  He states his shortness of breath has worsened over the last 2 days and admits to frequent cough attacks causing him to become lightheaded and significantly dyspneic.  The patient's accompanying symptoms include fever, chills, cough, dizziness, lightheadedness, nausea and fatigue.  The patient denies any chest pain, diarrhea, loss of taste or smell, vomiting or abdominal pain.  The patient has been using albuterol nebulizer treatments at home without relief of symptoms. The patient denies ever being on oxygen supplementation in the past.  The patient is vaccinated against COVID-19.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use.  The patient is a former smoker, quit 5 years ago.   The patient presents via EMS - his oxygen saturation was 87% on room air EN route, patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%.  Upon arrival to ED patient's temperature is 100.9°, heart rate 91, respirations 18, pulse ox 93% on 4 L oxygen via nasal cannula, blood pressure 125/94.  Chest x-ray reveals patchy bilateral pulmonary infiltrate/airspace disease consistent with COVID-19 pneumonia.  Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 112, calc Osmo 266, CRP 12.70, D-dimer 0.78.  Patient received 1 g p.o. Tylenol, DuoNeb x1, 500 mg IV azithromycin, 1 g IV Rocephin, 6 mg IV Decadron in ED.  12/6/21: 59-year-old man who presented worsening fever, myalgias, shortness of breath following diagnosis of COVID-19 infection 3 days prior.  He was found to be hypoxic on evaluation in the emergency department requiring initiation of supplemental oxygen, Chest x-ray demonstrated bilateral patchy infiltrates.  He was admitted to the hospitalist service where he was started on treatment with IV Decadron, remdesivir and empiric antibiotic therapy.  Abruptly worsening oxygen requirements were noted requiring initiation of high-flow oxygen up to 12 liters/minute.  Pulmonary was consulted, he was given a dose of Actemra with marked in improvement in CRP levels and subsequent improvement in oxygen requirements.  Oxygen walk was done for home determination done today, he did not meet criteria for home oxygen at this time.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/30/21 (ER8727) Pfizer Dose 2 4/21/21 (ER8731) COVID Positive 11/30/21 COVID Positive 12/2/21  12/2/21: Patient is a 59-year-old male with past medical history significant for COPD, OSA on CPAP, obesity, hyperlipidemia, history of PE currently anticoagulated on Eliquis, IFG, hypertension, and anxiety.  The patient presents to the ED today via EMS from home with complaints of worsening shortness of breath.  The patient tested positive for COVID-19 3 days ago.  The patient states his symptoms started on 11/26/2021.  He states his shortness of breath has worsened over the last 2 days and admits to frequent cough attacks causing him to become lightheaded and significantly dyspneic.  The patient's accompanying symptoms include fever, chills, cough, dizziness, lightheadedness, nausea and fatigue.  The patient denies any chest pain, diarrhea, loss of taste or smell, vomiting or abdominal pain.  The patient has been using albuterol nebulizer treatments at home without relief of symptoms. The patient denies ever being on oxygen supplementation in the past.  The patient is vaccinated against COVID-19.  The patient denies any alcohol abuse, illicit drug abuse or tobacco use.  The patient is a former smoker, quit 5 years ago.   The patient presents via EMS - his oxygen saturation was 87% on room air EN route, patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%.  Upon arrival to ED patient's temperature is 100.9°, heart rate 91, respirations 18, pulse ox 93% on 4 L oxygen via nasal cannula, blood pressure 125/94.  Chest x-ray reveals patchy bilateral pulmonary infiltrate/airspace disease consistent with COVID-19 pneumonia.  Patient's laboratory findings are significant for sodium 132, chloride 95, glucose 112, calc Osmo 266, CRP 12.70, D-dimer 0.78.  Patient received 1 g p.o. Tylenol, DuoNeb x1, 500 mg IV azithromycin, 1 g IV Rocephin, 6 mg IV Decadron in ED.  12/6/21: 59-year-old man who presented worsening fever, myalgias, shortness of breath following diagnosis of COVID-19 infection 3 days prior.  He was found to be hypoxic on evaluation in the emergency department requiring initiation of supplemental oxygen, Chest x-ray demonstrated bilateral patchy infiltrates.  He was admitted to the hospitalist service where he was started on treatment with IV Decadron, remdesivir and empiric antibiotic therapy.  Abruptly worsening oxygen requirements were noted requiring initiation of high-flow oxygen up to 12 liters/minute.  Pulmonary was consulted, he was given a dose of Actemra with marked in improvement in CRP levels and subsequent improvement in oxygen requirements.  Oxygen walk was done for home determination done today, he did not meet criteria for home oxygen at this time.  He has been discharged in stable medical condition to continue outpatient follow-up.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Dyspnoea exertional, Echocardiogram, Electrocardiogram, Fatigue
Clinical narrative: Severe fatigue, muscle weakness lasting three weeks.  Dyspnea on exertion lasted several months.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Magnetic resonance imaging neck, Metabolic function test, Muscular weakness, Troponin
Clinical narrative: Severe fatigue, muscle weakness lasting three weeks.  Dyspnea on exertion lasted several months.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: hosptialized with breakthrough COVID infection
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired at time of administration.  It was past bud of 10 weeks in the fridge.  It expired on 3/30/22.  Called patient to discuss cdc recommendation for re-vaccination.  Patient did schedule appointment for re-vax.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Oropharyngeal pain, Pain
Clinical narrative: I had a sore throat and cough when I woke up in the morning. I felt really fatigue and had body aches. I took cough suppressants and my daily medications to help reduce my cough. I went to the clinic to get tested on 05/02/2022, and it came back positive for COVID-19.  I quarantined for 10 days and have felt better since then and just returned back to work on 05/16/2022 after my PCR test came back negative on 05/12/2022.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a sore throat and cough when I woke up in the morning. I felt really fatigue and had body aches. I took cough suppressants and my daily medications to help reduce my cough. I went to the clinic to get tested on 05/02/2022, and it came back positive for COVID-19.  I quarantined for 10 days and have felt better since then and just returned back to work on 05/16/2022 after my PCR test came back negative on 05/12/2022.
Age: 76.0
Sex: M
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Pt admit to hospital with Covid.  Pt had Covid Vaccination
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was administered to patient on 04/25/22.  Expiry date as per manufacturer was 05/31/2022.  But beyond date use was 04/19/2022.  Talked to patient they had no adverse reaction.  There was no temperature excursion during storage of the vaccine since the time we received at pharmacy.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anal incontinence, Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Patient with Moderna COVID vaccinations who admitted to hospital with COVID complications and ultimately died on hospice services.  Hospitalist d/f note below:  "61 YO year old male with a history of polycystic kidney disease s/p renal transplant, left breast cancer, T-cell leukemia, T2DM, and hypertension who presented to the ED on 5/1/2022 with generalized weakness.    2 weeks prior to admission had exposure to a sick contact, since then experiencing generalized weakness and fatigue with chills, lightheadedness, shortness of breath, and a productive cough or thick, clear sputum. His brother, went to check on him the day of admission and found him in his room covered and feces and confused. Labs and chest xray were consistent with COVID19 pneumonia and he was treated with steroids, remdesivir and supportive treatment. Pulmonology was consulted which suggested starting anti-biotics for concerns of superimposed bacterial pneumonia and aggressive diuresis. Fungal cultures revealed a reactive Coccidiodes ab and he was started on voriconazole given his immunocompromised state, though there can be cross reactivity with histoplasma ab. He is DNR/DNI aggressive care so bipap,cpap were used for his oxygen needs. Throughout his course his respiratory status continually declined and he developed worsening kidney failure. Palliative was consulted to discuss goals of care. Brother is the patients POA and as the patients status continued to decline, family decided to transition to comfort care and hospice was consulted for GIP status, and was accepted. Patient will transition to hospice inpatient care. "  After admitting to hospice services patient died.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Confusional state, Death, Dizziness, Dyspnoea
Clinical narrative: Patient with Moderna COVID vaccinations who admitted to hospital with COVID complications and ultimately died on hospice services.  Hospitalist d/f note below:  "61 YO year old male with a history of polycystic kidney disease s/p renal transplant, left breast cancer, T-cell leukemia, T2DM, and hypertension who presented to the ED on 5/1/2022 with generalized weakness.    2 weeks prior to admission had exposure to a sick contact, since then experiencing generalized weakness and fatigue with chills, lightheadedness, shortness of breath, and a productive cough or thick, clear sputum. His brother, went to check on him the day of admission and found him in his room covered and feces and confused. Labs and chest xray were consistent with COVID19 pneumonia and he was treated with steroids, remdesivir and supportive treatment. Pulmonology was consulted which suggested starting anti-biotics for concerns of superimposed bacterial pneumonia and aggressive diuresis. Fungal cultures revealed a reactive Coccidiodes ab and he was started on voriconazole given his immunocompromised state, though there can be cross reactivity with histoplasma ab. He is DNR/DNI aggressive care so bipap,cpap were used for his oxygen needs. Throughout his course his respiratory status continually declined and he developed worsening kidney failure. Palliative was consulted to discuss goals of care. Brother is the patients POA and as the patients status continued to decline, family decided to transition to comfort care and hospice was consulted for GIP status, and was accepted. Patient will transition to hospice inpatient care. "  After admitting to hospice services patient died.